The usefulness of OK-432 for the treatment of postoperative chylothorax
in a low-birth-weight infant with trisomy 18
- Yoshiaki Takahashi
, - Yoshiaki Kinoshita,
- Takashi Kobayashi,
- Yuhki Arai,
- Toshiyuki Ohyama,
- Naoki Yokota,
- Koichi Saito,
- Yu Sugai,
- Shoichi Takano
Yoshiaki Kinoshita
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileTakashi Kobayashi
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileYuhki Arai
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileToshiyuki Ohyama
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileNaoki Yokota
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileKoichi Saito
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileYu Sugai
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileShoichi Takano
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileAbstract
Chylothorax is a rare but life-threatening condition in neonates. We
herein report the successful use of OK-432 for a low-birth-weight infant
with trisomy 18 who developed refractory chylothorax after thoracic
surgery. Increasing the concentration of OK-432 seems useful in cases
with a lot of pleural effusion.02 Mar 2022Submitted to Clinical Case Reports 02 Mar 2022Submission Checks Completed
02 Mar 2022Assigned to Editor
15 Mar 2022Reviewer(s) Assigned
24 Mar 2022Review(s) Completed, Editorial Evaluation Pending
18 Apr 2022Editorial Decision: Accept
